| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |